ROCKLATAN 0.02%-0.005% EYE DRP

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%
$139.6390per ML

Strength

.05; .2 mg/mL; mg/mL

NDC

70727052925

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC; TOPICAL

Last Updated

1/1/2026

Approval Type

New Drug (NDA)

FDA Application

NDA208259

On Market Since

3/12/2019

Pharmacological Classes

Rho Kinase Inhibitor
Rho Kinase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.1%

1Y

+2.8%

3Y

+10.2%

5Y

+21.5%

All

+38.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.